NCT06525051Completed
Effect of Tiotropium on Eye Findings in the Treatment of Chronic Obstructive Pulmonary Disease
Examination of the Effect of Handhaler Tiotropium, a Long-acting Anticholinergic, on Anterior Chamber Parameters
Source: ClinicalTrials.gov · Last updated 29 Jul 2024
Brief summary (registry, in English)
This study aimed to examine the effect of Tiotropium, which is used in the treatment of COPD, on eye symptoms.The study was conducted prospectively. Patients were examined in three groups. Thirty-six patients were included in each group in the study. Anterior chamber parameters, intraocular pressure values, and photopic-mesopic pupil diameters were measured at the initial visit for Group 1 and Group 2 patients, and at the third month of treatment for Group 3 patients.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 108 (actual)
- First submitted
- 21 Jul 2024
- Start date
- 23 Oct 2023
- Primary completion date
- 30 Mar 2024
- Lead sponsor
- Giresun University
- NCT number
- NCT06525051
What you commit to
- Study type: Observational
- Participants enrolled: 108
- From 23 Oct 2023 to the primary completion date, 30 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- 1\. Patients under 18 years of age 2. Pregnant women 3. Without written consent 4. Receiving the following medications: 4a. Inhaled and/or systemic steroids 4b. Long-acting inhaled beta-2 agonists 4c. Combined long-acting beta-2 agonists and long-acting anticholinergics 4d. Topical medication
- 5\. Patients with the following comorbidities 5a. Glaucoma 5b. Cataract 5c. Hypertension 5d. Diabetes Mellitus 5e. Patients had previously undergone eyelid, refractive, or intraocular surgery, those with corneal diseases altering the corneal surface
- 6\. Patients receiving topical medications for chronic eye diseases 7. Patients receiving medications for diabetes mellitus 8. Patients receiving medications for hypertension 8. Patients those using contact lenses
Who the study is looking for
- Clinical diagnosis of COPD
- Not receiving any COPD treatment
- Receiving only 18 mcg Tiotropium treatment
- With written consent
Age in the registry: 47 years to 82 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Giresun Training and Research Hospital Coordinator of this site? Confirm its status | Giresun | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.